Clinical Trial Update: Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluating a 6-month sustained-release formulation of leuprolide acetate for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuprolide acetate (Leuprolide acetate)

Snippet

Sponsor: Abbott | Conditions: Prostatic Neoplasms | NA | Status: COMPLETED